Antibiotic resistance in community-acquired urinary tract infections. Did the COVID-19 pandemic cause a change?

Introduction: This study aimed to evaluate the antimicrobial resistance rates before and during the coronavirus disease 2019 (COVID-19) pandemic. Methodology: 897 positive urine cultures collected from outpatients of all ages between January 1, 2017, and December 31, 2022, were analyzed. The anti...

Full description

Saved in:
Bibliographic Details
Main Authors: Emine Unal Evren, Hakan Evren, Nilufer Galip
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2024-09-01
Series:Journal of Infection in Developing Countries
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/18844
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850148182575546368
author Emine Unal Evren
Hakan Evren
Nilufer Galip
author_facet Emine Unal Evren
Hakan Evren
Nilufer Galip
author_sort Emine Unal Evren
collection DOAJ
description Introduction: This study aimed to evaluate the antimicrobial resistance rates before and during the coronavirus disease 2019 (COVID-19) pandemic. Methodology: 897 positive urine cultures collected from outpatients of all ages between January 1, 2017, and December 31, 2022, were analyzed. The antibiotic susceptibility tests (AST) were analyzed by using an automated VITEK 2 (Biomerieux, Marcy-l`Étoile, France) compact system. AST results were interpreted according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria. The significance of resistance rates was tested with the Pearson’s Chi-squared test and risk factors of extended-spectrum beta-lactamases (ESBL) positiveness were identified with binary logistic regression. Results: E. coli (n = 774) and K. pneumoniae (n = 123) were isolated in 86.3% and 13.7% of the patients, respectively. During this period of six years before and during pandemic, the highest resistance rate was found for cefuroxime axetil (49.8%) and the lowest for nitrofuratoin (6.0%). Statistically significant increases in resistance compared to the pre-pandemic period were only determined for cefixime (37.2 vs 46.0%) and ceftriaxone (37.6 vs 46.1%) (p = 0.010). ESBL positivity was the most important factor that statistically increased resistance for all antibiotics (p < 0.001 for all). Being male [OR (95% CI) 1.56 (1.13-2.15)] and presenting to the clinic after the pandemic period [1.4 (1.1-1.8)] were found to increase ESBL positiveness significantly. Conclusions: Ceftriaxone and Cefixime resistance rates and ESBL positivity among the uropathogens E. coli and K. pneumoniae increased during the pandemic compared with the pre-pandemic period. ESBL positivity was higher in males.
format Article
id doaj-art-aa06ef6ae01f4110afe75398756107ff
institution OA Journals
issn 1972-2680
language English
publishDate 2024-09-01
publisher The Journal of Infection in Developing Countries
record_format Article
series Journal of Infection in Developing Countries
spelling doaj-art-aa06ef6ae01f4110afe75398756107ff2025-08-20T02:27:19ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802024-09-011809.110.3855/jidc.18844Antibiotic resistance in community-acquired urinary tract infections. Did the COVID-19 pandemic cause a change?Emine Unal Evren0Hakan Evren1Nilufer Galip2Department of Infectious Diseases and Clinical Microbiology; School of Medicine, University of Kyrenia, Kyrenia, CyprusDepartment of Infectious Diseases and Clinical Microbiology; School of Medicine, University of Kyrenia, Kyrenia, CyprusDivision of Allergy and Immunology, Department of Pediatrics; School of Medicine, University of Kyrenia, Kyrenia, Cyprus Introduction: This study aimed to evaluate the antimicrobial resistance rates before and during the coronavirus disease 2019 (COVID-19) pandemic. Methodology: 897 positive urine cultures collected from outpatients of all ages between January 1, 2017, and December 31, 2022, were analyzed. The antibiotic susceptibility tests (AST) were analyzed by using an automated VITEK 2 (Biomerieux, Marcy-l`Étoile, France) compact system. AST results were interpreted according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria. The significance of resistance rates was tested with the Pearson’s Chi-squared test and risk factors of extended-spectrum beta-lactamases (ESBL) positiveness were identified with binary logistic regression. Results: E. coli (n = 774) and K. pneumoniae (n = 123) were isolated in 86.3% and 13.7% of the patients, respectively. During this period of six years before and during pandemic, the highest resistance rate was found for cefuroxime axetil (49.8%) and the lowest for nitrofuratoin (6.0%). Statistically significant increases in resistance compared to the pre-pandemic period were only determined for cefixime (37.2 vs 46.0%) and ceftriaxone (37.6 vs 46.1%) (p = 0.010). ESBL positivity was the most important factor that statistically increased resistance for all antibiotics (p < 0.001 for all). Being male [OR (95% CI) 1.56 (1.13-2.15)] and presenting to the clinic after the pandemic period [1.4 (1.1-1.8)] were found to increase ESBL positiveness significantly. Conclusions: Ceftriaxone and Cefixime resistance rates and ESBL positivity among the uropathogens E. coli and K. pneumoniae increased during the pandemic compared with the pre-pandemic period. ESBL positivity was higher in males. https://jidc.org/index.php/journal/article/view/18844uropathogenCOVID-19resistancepandemic
spellingShingle Emine Unal Evren
Hakan Evren
Nilufer Galip
Antibiotic resistance in community-acquired urinary tract infections. Did the COVID-19 pandemic cause a change?
Journal of Infection in Developing Countries
uropathogen
COVID-19
resistance
pandemic
title Antibiotic resistance in community-acquired urinary tract infections. Did the COVID-19 pandemic cause a change?
title_full Antibiotic resistance in community-acquired urinary tract infections. Did the COVID-19 pandemic cause a change?
title_fullStr Antibiotic resistance in community-acquired urinary tract infections. Did the COVID-19 pandemic cause a change?
title_full_unstemmed Antibiotic resistance in community-acquired urinary tract infections. Did the COVID-19 pandemic cause a change?
title_short Antibiotic resistance in community-acquired urinary tract infections. Did the COVID-19 pandemic cause a change?
title_sort antibiotic resistance in community acquired urinary tract infections did the covid 19 pandemic cause a change
topic uropathogen
COVID-19
resistance
pandemic
url https://jidc.org/index.php/journal/article/view/18844
work_keys_str_mv AT emineunalevren antibioticresistanceincommunityacquiredurinarytractinfectionsdidthecovid19pandemiccauseachange
AT hakanevren antibioticresistanceincommunityacquiredurinarytractinfectionsdidthecovid19pandemiccauseachange
AT nilufergalip antibioticresistanceincommunityacquiredurinarytractinfectionsdidthecovid19pandemiccauseachange